Today: September 20, 2024
Today: September 20, 2024

FuboTV's antitrust trial against Disney, media giants set to begin in October 2025

Toy figures of people are seen in front of the displayed Fubo TV logo, in this illustration
September 12, 2024
Reuters

(Reuters) - FuboTV's antitrust trial against the launch of a new sports streaming service by Walt Disney, Fox and Warner Bros Discovery is set to begin on Oct. 6 next year, according to a court filing on Thursday.

Read More

Related

Business|Sports|Technology

Nike's new CEO may look to fix retailer ties in sales revival push

Nike's new CEO will likely focus on repairing relations with retailers to boost demand, a strategy that took a back seat under outgoing chief John Donahoe, industry

Nike's new CEO may look to fix retailer ties in sales revival push
Business|Europe|News|Travel

Brussels Airlines to cancel most Oct. 1 flights due to strike

Brussels Airlines said on Friday that it would cancel most of its flights on Oct. 1 due to a Belgian national strike of security workers.

Brussels Airlines to cancel most Oct. 1 flights due to strike
Business|Europe|Finance

Germany must oppose UniCredit takeover of Commerzbank, bank employees and union warn

Commerzbank employees and a prominent labour union on Friday called on the German government to oppose a takeover of the German lender by Italy's UniCredit.

Germany must oppose UniCredit takeover of Commerzbank, bank employees and union warn
Share This

Popular

Americas|Business|Sports|Technology

Brazil’s online gambling craze may be hitting consumer spending

Brazil’s online gambling craze may be hitting consumer spending
Asia|Business|Economy|News

China's August youth jobless rate rises to nine-month high

China's August youth jobless rate rises to nine-month high
Business|Economy|Finance

Investment advisers urge clients away from cash after Fed rate cut

Investment advisers urge clients away from cash after Fed rate cut
Business|Europe|Health|Science

Sanofi says tolebrutinib drug delayed progressive MS by 31%

Sanofi says tolebrutinib drug delayed progressive MS by 31%